Evidence map›Paper›PMID 42699139›Full record

ArticleRwanda journal of medicine and health sciences2026

Thalassemia in Iraq: Time to Reform Policy.

Halima Adill Abdulrahman, Ahmed A Mosa, Nawfal R Hussein

Abstract read
In one paragraph

Article in Rwanda journal of medicine and health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Halima Adill AbdulrahmanDepartment of Clinical Sciences, College of Medicine, University of Zakho, Kurdistan Region of Iraq.
Ahmed A MosaDepartment of Clinical Sciences, College of Medicine, University of Zakho, Kurdistan Region of Iraq.
Nawfal R HusseinDepartment of Biomedical Sciences, College of Medicine, University of Zakho, Kurdistan Region of Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thalassemia is one of the most common hemoglobinopathies worldwide, particularly within the Middle Eastern demographics. Despite the existence of a nationwide screening program in Iraq and a decline in disease incidence, its optimal effectiveness remains uncertain, as β-thalassemia prevalence continues to rise. This paper seeks to evaluate the weaknesses of the thalassemia screening program in Iraq. It also suggests actionable strategies for policy change to further reduce disease incidence. Additionally, the discussed concepts can be applicable to other regions facing a similar burden. Factors like widespread consanguineous marriage, inadequate public knowledge, and restricted access to prenatal diagnostic services impose further burden on prevention efforts. To attain national elimination of β-thalassemia in Iraq, the Ministry of Health, in collaboration with medical organizations, must promptly address these barriers by revising policies and substantially investing in essential services.

Indexed as

policy reformpremarital screeningpreventionscreeningThalassemia

Identifiers

PMID42699139
PMCPMC13542666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.